US Patent Issued to HORIZON THERAPEUTICS IRELAND DAC on July 28 for "Methods of treating systemic sclerosis and idiopathic pulmonary fibrosis" (Irish Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,086, issued on July 28, was assigned to HORIZON THERAPEUTICS IRELAND DAC (Dublin).

"Methods of treating systemic sclerosis and idiopathic pulmonary fibrosis" was invented by Farah Naseer Ali (Dublin) and Paul Peloso (Dublin).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are uses of crystalline forms of 2-(4-methoxy-3-(3-methylphenethoxy)benzamido)-2,3-dihydro-1H-indene-2-carboxylic acid in the treatment of diseases or conditions that would benefit by administration with an LPA1 receptor antagonist compound."

The patent was filed on March 2, 2023, under Application No. 18/177,487.

*For further information, including images, charts ...